Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hasan Sami Göksoy"'
Autor:
Sinem Civriz Bozdağ, Güldane Cengiz Seval, İpek Yönal Hindilerden, Fehmi Hindilerden, Neslihan Andıç, Mustafa Baydar, Lale Aydın Kaynar, Selami Koçak Toprak, Hasan Sami Göksoy, Berrin Balık Aydın, Ufuk Demirci, Ferda Can, Vildan Özkocaman, Eren Gündüz, Zeynep Tuğba Güven, Zübeyde Nur Özkurt, Sinan Demircioğlu, Meral Beksaç, İdris İnce, Umut Yılmaz, Hilal Eroğlu Küçükdiler, Elgün Abishov, Boran Yavuz, Ünal Ataş, Yaşa Gül Mutlu, Volkan Baş, Fahir Özkalemkaş, Hava Üsküdar Teke, Vildan Gürsoy, Serhat Çelik, Rafiye Çiftçiler, Münci Yağcı, Pervin Topçuoğlu, Özcan Çeneli, Hamza Abbasov, Cem Selim, Muhlis Cem Ar, Orhan Kemal Yücel, Sevil Sadri, Canan Albayrak, Ahmet Muzaffer Demir, Nil Güler, Muzaffer Keklik, Hatice Terzi, Ali Doğan, Zeynep Arzu Yegin, Meltem Kurt Yüksel, Soğol Sadri, İrfan Yavaşoğlu, Hüseyin Saffet Beköz, Tekin Aksu, Senem Maral, Veysel Erol, Leylagül Kaynar, Osman İlhan, Ali Zahit Bolaman, Ömür Gökmen Sevindik, Arzu Akyay, Muhit Özcan, Günhan Gürman, Şule Ünal, Yasemin Yavuz, Reyhan Diz Küçükkaya, Güner Hayri Özsan
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 1, Pp 43-54 (2022)
Objective: Patients with solid malignancies are more vulnerable to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection than the healthy population. The outcome of SARS-CoV-2 infection in highly immunosuppressed populations, such as
Externí odkaz:
https://doaj.org/article/ef03a300a9a44beba39b3be598d50f71
Autor:
Murat Sevmis, Sema Aktas, Utku Alkara, Hakan Kilercik, Hasan Sami Göksoy, Murathan Uyar, Sinasi Sevmis
Publikováno v:
Transplantation Proceedings. 54:197-201
Autor:
Nurcan Özçelik, Hasan Sami Göksoy, Serkan Güvenç, Deniz Goren Sahin, Emine Tülay Özçelik, Burcu Kurt Yildirim, Fehmi Hindilerden, Mutlu Arat, Reyhan Diz Küçükkaya
Publikováno v:
Ege Tıp Dergisi. 59:109-112
Amaç: Primer miyelofibrozis (PMF), kronik miyeloproliferasyon, atipik megakaryositik hiperplazi ve kem k l ğ f broz s le karakter ze klonal b r kök hücre hastalığıdır. Bu hastalarda günümüzde halen göster leb lm ş tek şifa sağlayıcı
Autor:
Mutlu Arat, Hasan Sami Göksoy
Publikováno v:
Transfusion and Apheresis Science. 54:91-98
Allogeneic (allo) hematopoietic stem cell transplantation (HSCT) is the only curative option for many malignant and benign hematological disorders. It seems hopeless for patients who relapse after this strategy. In the era of developing breakthrough
Autor:
Mutlu Arat, Deniz Goren Sahin, Fehmi Hindilerden, Burcu Kurt, Tulay Ozcelik, Hasan Sami Göksoy, Reyhan Diz Küçükkaya, Nurcan Özçelik, Serkan Guvenc
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:S344-S345
Autor:
Hasan Sami Göksoy, Reyhan Diz Küçükkaya, Tulay Ozcelik, Nurcan Özçelik, Mutlu Arat, Deniz Goren Sahin, Serkan Güvenç, Fehmi Hindilerden
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S260-S261
Autor:
Serkan Guvenc, Mutlu Arat, Reyhan Diz Küçükkaya, Hasan Sami Göksoy, Tulay Ozcelik, Fehmi Hindilerden
Publikováno v:
Blood. 124:5921-5921
Allogeneic hematopoetic cell transplantation (allo-HCT) is currently the only curative treatment option for non-M3 AML in first or second remission (CR1, CR2). Cytogenetic risk factors, pretransplant disease status and factors apart from leukemia cou